Related Experiment Video
Updated: Jul 3, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
Large Language Models Meet Biomedical Knowledge Graphs for Mechanistically Grounded Therapeutic Prioritization
DrugKLM, a new framework, enhances drug repurposing by combining knowledge graphs and large language models for better candidate prioritization. It identifies biologically plausible drugs, improving therapeutic discovery and clinical application.
Area of Science:
- Computational Biology
- Pharmacology
- Bioinformatics
Background:
- Current drug repurposing methods struggle to differentiate biologically plausible candidates from those with historical associations.
- Existing approaches lack robust mechanisms for prioritizing novel therapeutic applications based on underlying biology.
Purpose of the Study:
- To introduce DrugKLM, a hybrid framework integrating biomedical knowledge graphs and large language model (LLM) mechanistic reasoning.
- To enable mechanistically grounded therapeutic prioritization for drug repurposing.
- To improve the identification of biologically plausible drug candidates.
Main Methods:
- Developed DrugKLM, a framework combining knowledge graph structure with LLM-based mechanistic reasoning.
- Evaluated DrugKLM on benchmark datasets against knowledge graph-only and LLM-only baselines.
- Assessed the functional alignment of DrugKLM confidence scores with molecular phenotypes and survival data.
- Conducted expert curation across five cancer types to analyze prioritization behavior.
Main Results:
- DrugKLM outperformed existing baselines, including TxGNN, in therapeutic prioritization.
- DrugKLM confidence scores showed functional alignment with molecular phenotypes, correlating with improved survival in 12 TCGA cancers.
- The framework preferentially captured biologically perturbational signals over historical indication patterns.
- Expert curation confirmed DrugKLM's ability to prioritize candidates with coherent mechanistic rationale and clinical context.
Conclusions:
- DrugKLM is an effective evidence-integrative framework for therapeutic prioritization in drug repurposing.
- The framework translates heterogeneous biomedical data into mechanistically interpretable and clinically relevant hypotheses.
- DrugKLM advances the field by providing mechanistically grounded guidance for identifying novel drug candidates.
Related Concept Videos
Mechanistic Models: Overview of Compartment Models
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacodynamic Models: Overview

